Carolina Reis Oliveria
Claire Chang
Having immigrated from Korea to the US when she was 12 years old, Claire is bilingual and bicultural, which has always given her the unique perspective of being both an insider and outsider able to bridge different perspectives. Combining her passions for connecting people and helping them realize their dreams, Claire launched a global accelerator in 2014 which impacted over 200 Korean startups' ability to expand to the US market. In 2018, Claire launched SVBeautyTech, the first-ever independent beauty-tech accelerator, to provide a cohort of mostly female beauty-tech founders access to the Silicon Valley resources previously enjoyed almost exclusively by male, locally networked tech entrepreneurs. Leveraging her global accelerator network and broad brand connections, Claire is excited to work with passionate innovators and disruptors working at the intersection of technology, beauty & wellness.
igniteXL Venturs is a Silicon Valley-based global seed fund investing in game-changing entrepreneurs at the intersection of technology, beauty and wellness. With the advancement of technology and the rise of conscious consumers who demand authenticity, sustainability, transparency, and inclusivity, the wellness industry is undergoing digital and cultural transformation. And that transformation represents excellent investment opportunities to investors with high margins, recurring and engaged customers, with attractive exit opportunities.
Osmaan Shah
Osmaan is the founder and CEO of Formulate, a customization manufacturing platform and consumer brand that offers personalized hair, scalp, and skin care products.
Tomasz Rygiel
Kiran Sonaje
Mariann Micsinai-Balan
Fia Navntoft
Leo Mavely
Leo Mavely is the CEO of Axio Biosolutions a medtech company focused on novel
biomaterials for advanced wound care and surgical solutions. Axiostat® its flagship product
which was developed to reduce the mortality due to traumatic bleeding from life threatening
injuries and is approved in over 45 countries and used by major armed forces globally. Their
more recent offering, Maxiocel is a 100% chitosan based advanced woundcare platform that
is CE marked and now used across Europe.
A bioengineer by qualification, Leo invented the core technology of Axio and is passionate
about building affordable healthcare products. Leo holds multiple patents and publications in
the field of novel biomaterials for medical tech applications.
Leo was featured in the list of 40 under 40 emerging business leaders by Fortune Magazine
consecutively in 2016, 2017, 2018 and 2019 and in the list of 35 under 35 entrepreneurs by
Entrepreneur magazine in 2020. He was the recipient of Silicon valley challenge 2014,
Anjani Mashelkar Inclusive Innovation Award 2013, CNBC Samsung Social Innovation
Award 2012 and was invited speaker at Indian Science congress 2010.
Axio has raised over $20mn in venture funding from Accel Partners, Ratan Tata’s UC-RNT
Fund, Omidyar network, Chiratate venture and TrueScale capital. Axio has its state of the art
R&D and manufacturing facility in India and is head quartered in Cambridge, USA.
Aaron Morales
